/PRNewswire/ On April 21, 2023, OBiO Technology (Shanghai) Corp., Ltd. ("OBiO" or "the Company"), a leading gene and cell therapy CDMO in China, announced.
/PRNewswire/ On March 22, 2022, OBiO Technology (Shanghai) Corp., Ltd. ("OBiO" or "the Company"), has completed its initial public offering ("IPO") process.
SHANGHAI, March 22, 2022 /PRNewswire/ On March 22, 2022, OBiO Technology (Shanghai) Corp., Ltd. ("OBiO" or "the Company"), has completed its initial public offering ("IPO") process and started